Horm Metab Res 1994; 26(11): 526-530
DOI: 10.1055/s-2007-1001749
Minisymposium

© Georg Thieme Verlag, Stuttgart · New York

Implantable Electrocatalytic Glucose Sensor

W. Lager1 , I. v. Lucadou1 , H. Nischik1 , T. Nowak2 , W. Preidel, L. Ruprecht3 , M. J. Stanzel1 , V. Tegeder1
  • 1Corporate Research and Development, Siemens AG, Erlangen
  • 2Institute of Zoology, University of Erlangen, Erlangen
  • 3Forschungszentrum für Umwelt und Gesundheit (GSF), Munich, Germany
Further Information

Publication History

Publication Date:
14 March 2008 (online)

Summary

An electrocatalytic glucose sensor for in vivo application has been developed to determine the glucose level in blood and further to control the insulin dosage in a closed loop system for diabetes therapy. The principle of the electrocatalytic glucose sensor is based on the direct electrochemical oxidation of glucose at a membrane-covered platinum electrode. For a possible clinical application the sensor was built as a catheter. A set of implantations in the vena cava of sheep demonstrated the potential feasibility of the sensor. The sensor values were simultaneously checked by the enzymatic analysis of glucose in blood samples drawn separately from a femoral vein. It was possible to determine the glucose concentration in sheep for more than 130 days with tolerable deviations from glucose reference measurements. The mean error was 2.5 mmol/l. One of the catheters was explanted after 211 days and the histological examination revealed a good biocompatibility of all materials used. In additional experiments, the differences of the glucose concentration in vena cava as well as in the anterior and posterior femoral veins of a sheep were examined during glucose tolerance tests. These experiments verified our method of in vivo calibration of the long-term implantable glucose sensor.

    >